Providence Investment Company Limited

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 5
Rounds per year 2.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.64
Exits 1
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
  • Biopharma
  • Health Care
Summary

The company was established in North America in United States. The main department of described VC is located in the Germany.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Definigen, evonetix, Phico Therapeutics. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Biopharma, Therapeutics.

Comparing to the other companies, this Providence Investment Company Limited performs on 19 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. The high activity for fund was in 2013. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2014.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Providence Investment Company Limited, startups are often financed by UK Innovation & Science Seed Fund, Nesta Ventures, Morningside Venture Partners. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Morningside Venture Partners, Avlar BioVentures. In the next rounds fund is usually obtained by Morningside Venture Partners, Nesta Ventures, UK Innovation & Science Seed Fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Providence Investment Company Limited:
Typical Co-investors
Providence Investment Company Limited is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Providence Investment Company Limited:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

evonetix

Biopharma
Biotechnology
Life Science
$30M02 Mar 2020 Uttlesford, England, United Kingdom

evonetix

Biopharma
Biotechnology
Life Science
$12M30 Jan 2018 Uttlesford, England, United Kingdom

Definigen

Biotechnology
Health Care
Pharmaceutical
$2M23 May 2016 Cambridge, England, United Kingdom

CellCentric

Biotechnology
Medical
Therapeutics
19 Oct 2015 Cambridge, England, United Kingdom

CellCentric

Biotechnology
Medical
Therapeutics
$5M25 Jun 2013 Cambridge, England, United Kingdom

Horizon Discovery

Biopharma
Biotechnology
Genetics
Health Diagnostics
$9M03 Jun 2013 Cambridge, England, United Kingdom

Horizon Discovery

Biopharma
Biotechnology
Genetics
Health Diagnostics
$15M13 Sep 2011 Cambridge, England, United Kingdom

Phico Therapeutics

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$1M01 Jan 2009 United Kingdom, England

CellCentric

Biotechnology
Medical
Therapeutics
$4M02 Oct 2007 United Kingdom, England

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Providence Investment Company Limited?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: